| Date | Title | Description |
| 25.04.2024 | Dutch-based Flindr Therapeutics secures €20M to discover and develop precision oncology therapeutics | Read this article in:
Netherlands-based Flindr Therapeutics, a company focused on precision cancer treatments, announced that it has secured €20M in a Series A round of funding.
This funding will help advance the Dutch company’s cancer trea... |
| 24.04.2024 | Flindr raises €20 million in Series A | OSS, Netherlands, 24 April 2024 – Flindr Therapeutics B.V. (“Flindr” or “the Company”), a precision oncology therapeutics company, today announces a €20 million Series A financing to advance its pipeline of first-in-class, small molecule in... |
| 24.04.2024 | Flindr Therapeutics Raises €20M in Series A Financing | Flindr Therapeutics, an Oss, the Netherlands-based precision oncology therapeutics company, raised €20M in Series A funding.
The round was led by V-Bio Ventures, with participation from JJDC, Inc. (JJDC), QBIC Fund, Flanders Future Tech Fun... |
| - | Flindr Therapeutics | - |
